Biora Therapeutics (BIOR) PT Lowered to $50 at H.C. Wainwright

October 2, 2023 6:48 AM EDT Send to a Friend
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Biora Therapeutics (NASDAQ: BIOR) to $50.00 (from $65.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login